BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 27070462)

  • 1. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.
    Walia MK; Ho PM; Taylor S; Ng AJ; Gupte A; Chalk AM; Zannettino AC; Martin TJ; Walkley CR
    Elife; 2016 Apr; 5():. PubMed ID: 27070462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to sustained activation of the cAMP/Creb pathway activity in osteoblastic cells is enabled by loss of p53.
    Walia MK; Taylor S; Ho PWM; Martin TJ; Walkley CR
    Cell Death Dis; 2018 Aug; 9(9):844. PubMed ID: 30154459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
    Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
    J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.
    Ho PW; Goradia A; Russell MR; Chalk AM; Milley KM; Baker EK; Danks JA; Slavin JL; Walia M; Crimeen-Irwin B; Dickins RA; Martin TJ; Walkley CR
    Oncogene; 2015 May; 34(22):2922-33. PubMed ID: 25043296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The miR-15b-5p/PDK4 axis regulates osteosarcoma proliferation through modulation of the Warburg effect.
    Weng Y; Shen Y; He Y; Pan X; Xu J; Jiang Y; Zhang Q; Wang S; Kong F; Zhao S; Zhou D; Zhang Y
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2749-2757. PubMed ID: 30093112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
    Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
    Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation.
    Ng AJ; Walia MK; Smeets MF; Mutsaers AJ; Sims NA; Purton LE; Walsh NC; Martin TJ; Walkley CR
    PLoS Genet; 2015 Apr; 11(4):e1005160. PubMed ID: 25859855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in osteosarcomagenesis.
    Kafchinski LA; Jones KB
    Adv Exp Med Biol; 2014; 804():119-27. PubMed ID: 24924171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Protein Tyrosine Phosphatase Rptpζ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.
    Baldauf C; Jeschke A; Kanbach V; Catala-Lehnen P; Baumhoer D; Gerull H; Buhs S; Amling M; Nollau P; Harroch S; Schinke T
    PLoS One; 2015; 10(9):e0137745. PubMed ID: 26360410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS; Chen C; Berry JE; McCauley LK
    J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aplasia Ras homologue member Ⅰ overexpression inhibits tumor growth and induces apoptosis through inhibition of PI3K/Akt survival pathways in human osteosarcoma MG-63 cells in culture.
    Ye K; Wang S; Yang Y; Kang X; Wang J; Han H
    Int J Mol Med; 2015 Sep; 36(3):776-82. PubMed ID: 26165148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone-related protein confers chemoresistance by blocking apoptosis signaling via death receptors and mitochondria.
    Gagiannis S; Müller M; Uhlemann S; Koch A; Melino G; Krammer PH; Nawroth PP; Brune M; Schilling T
    Int J Cancer; 2009 Oct; 125(7):1551-7. PubMed ID: 19507249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
    van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
    J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local secretion of parathyroid hormone-related protein by an osteoblastic osteosarcoma (UMR 106-01) cell line results in growth inhibition.
    Pasquini GM; Davey RA; Ho PW; Michelangeli VP; Grill V; Kaczmarczyk SJ; Zajac JD
    Bone; 2002 Nov; 31(5):598-605. PubMed ID: 12477574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism.
    Kim H; Yoo S; Zhou R; Xu A; Bernitz JM; Yuan Y; Gomes AM; Daniel MG; Su J; Demicco EG; Zhu J; Moore KA; Lee DF; Lemischka IR; Schaniel C
    Proc Natl Acad Sci U S A; 2018 Nov; 115(47):E11128-E11137. PubMed ID: 30385632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoblast-specific inactivation of p53 results in locally increased bone formation.
    Liao N; Koehne T; Tuckermann J; Triviai I; Amling M; David JP; Schinke T; Luther J
    PLoS One; 2021; 16(11):e0249894. PubMed ID: 34793446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
    Qin Y; Ye J; Zhao F; Hu S; Wang S
    Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling.
    Linder M; Glitzner E; Srivatsa S; Bakiri L; Matsuoka K; Shahrouzi P; Dumanic M; Novoszel P; Mohr T; Langer O; Wanek T; Mitterhauser M; Wagner EF; Sibilia M
    EMBO Mol Med; 2018 Nov; 10(11):. PubMed ID: 30361264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic and proteomic analyses in bone tumor cells: Deciphering parathyroid hormone-related protein regulation of the cell cycle and apoptosis.
    Mak IW; Turcotte RE; Ghert M
    J Bone Miner Res; 2012 Sep; 27(9):1976-91. PubMed ID: 22508574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.